COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,542 Articles (22,881 medRxiv, 8,661 bioRxiv)

Most recent first Previous |  Page 1435: Articles 14341-14350  | Next

Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people
Whitaker, M., Elliott, J., Chadeau-Hyam, M., Riley, S., Darzi, A., Cooke, G., Ward, H., Elliott, P.
10.1101/2021.06.28.21259452 — Posted: 2021-07-03 Discussion: Offsite
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen
Limonta-Fernandez, M., Chinea-Santiago, G., Martin-Dunn, A. M., Gonzalez-Roche, D., Bequet-Romero, M., Marquez-Perera, G., Gonzalez-Moya, I., Canaan-Haden-Ayala, C., Cabrales-Rico, A., Espinosa-Rodriguez, L. A., Ramos-Gomez, Y., Andujar-Martinez, I., Gonzalez-Lopez, L. J., Perez de la Iglesia, M., Zamora-Sanchez, J., Cruz-Sui, O., Lemos-Perez, G., Cabrera-Herrera, G., Valdes-Hernandez, J., Martinez-Diaz, E., Pimentel-Vazquez, E., Ayala-Avila, M., Guillen-Nieto, G.
10.1101/2021.06.29.21259605 — Posted: 2021-07-03
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients
Gazit, S., Mizrahi, B., Kalkstein, N., Neuberger, A., Peretz, A., Mizrahi-Reuveni, M., Patalon, T.
10.1101/2021.06.29.21259579 — Posted: 2021-07-03
Neuropsychiatric disorders as risk factors and consequences of COVID-19: A Mendelian randomization study
XIANG, Y., QIU, J., ZHANG, R., CHAU, C. K.-L., RAO, S., SO, H.-C.
10.1101/2021.06.29.21259609 — Posted: 2021-07-03
Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021
Duarte, N., D'Mello, S., Duarte, N. A., Rocco, S., Van Wyk, J., Pillai, A. A., Liu, M., Williamson, T., Arora, R. K.
10.1101/2021.06.29.21259730 — Posted: 2021-07-03
A national survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications
Stead, M., Jessop, C., Angus, K., Bedford, H., Ussher, M., Ford, A., Eadie, D., MacGregor, A., Hunt, K., MacKintosh, A. M.
10.1101/2021.06.29.21259717 — Posted: 2021-07-03
Effectiveness of COVID-19 vaccines against variants of concern, Canada
Nasreen, S., He, S., Chung, H., Brown, K. A., Gubbay, J. B., Buchan, S. A., Wilson, S. E., Sundaram, M. E., Fell, D. B., Chen, B., Calzavara, A., Austin, P. C., Schwartz, K. L., Tadrous, M., Wilson, K., Kwong, J. C.
10.1101/2021.06.28.21259420 — Posted: 2021-07-03 Discussion: Onsite
Tracing and testing multiple generations of contacts to COVID-19 cases: cost-benefit tradeoffs
Kim, J., Chen, X., Nikpey, H., Rubin, H., Bidokhti, S. S., Sarkar, S.
10.1101/2021.06.29.21259723 — Posted: 2021-07-03
Predictors of Depression and Anxiety Symptoms in Brazil during COVID-19
Zhang, S. X., Huang, H., Li, J., Mayra, A.-P., Scheila, d. P. F., Jose, d. S. A.
10.1101/2021.06.28.21259409 — Posted: 2021-07-03
A new model of unreported COVID-19 cases outperforms three known epidemic-growth models in describing data from Cuba and Spain
Ramirez-Torres, E. E., Castaneda, A. R. S., Randez, L., Garcia, L. E. V., Cabrales, L. E. B., Sisson, S. A., Montijano, J. I.
10.1101/2021.06.29.21259707 — Posted: 2021-07-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).